Facebook
Twitter
LinkedIn
Forward
Cancer and cancer treatments can affect patient’s memory, concentration, and other aspects of cognition.
|
Donald Warne, MD, MPH, will describe health disparities and inequities related to American Indian cancer control. We will explore the legal basis for federally-funded health services to American Indians and the complexity of health policy at the federal, state and tribal levels that impact cancer control. We will provide a framework for health equity and a path forward to improve outcomes.
|
This lecture will provide education on the safety and benefit of exercise during and after cancer treatment, resources that we have available at UNC and how you can help your patients implement exe
|
In this presentation, Dr. Bryant will share strategies in collaborating with team members in both the inpatient and outpatient settings to optimize cancer care.
|
Jose Gaston Guillem, MD, MPH, MBA, will describe how at UNC Medical Center a team of experts carefully reviews each individual patient during a Weekly GI Tumor Board and collaboratively develop a treatment plan which defines the specific timing and sequence of care for each patient.
|
Melissa Jim, MPH will describe our IHS linkage and characterize patterns of cancer incidence among AI/AN by IHS Region. We will discuss sources of AI/AN cancer data. I will also explore the United States Cancer Statistics: Data Visualizations website to show how to find AI/AN cancer data by IHS Region. Accurate cancer data is crucial to develop public health strategies and programs to address cancer disparities.
|
Embracing Indigenous Wisdom in Evidence Based Cancer Prevention: A Path of Collaboration, Respect, and Insight on Duke’s Voyage” is a presentation that explores the partnership between modern scientific research and indigenous wisdom in the pursuit of effective cancer prevention strategies. It underscores the humility in learning from indigenous knowledge, and the discovery of insights that can enhance evidence-based approaches to cancer prevention.
|
Cancer survivors may face many unique psychosocial challenges. Melissa Holt, DNP, PMHNP-BC and Lisa Kanser, PsyD discuss Acceptance and Commitment Therapy (ACT) is an evidence-based psychotherapeutic approach that can effectively teach patients skills to manage these challenges after completing cancer treatment. We will take you through case vignettes to show you how ACT can be applied to this patient population.
|
Tailored for medical providers, this session led by a physical therapist addresses challenges like speech and swallowing difficulties or pelvic floor issues in gynecological cancer. Explore the pivotal role of physical therapy in survivorship care plans and delve into current research supporting interventions for head and neck, gynecological, breast cancer, and other oncological conditions. Emphasizing interdisciplinary collaboration, we'll discuss the synergy between medical providers and physical therapists in delivering optimal cancer care. Additionally, learn the art of patient education in oncology rehabilitation, empowering medical providers to effectively communicate the role of physical therapy in cancer care.
|
Patients undergoing treatment for cancer utilize many medications that have relevant drug-gene interactions. The use of pharmacogenomic testing can assist with drug selection, drug dosing, and the development of personalized medication monitoring plans. Amber Cipriani, PharmD, BCOP, will describe some common examples of drug-gene interactions relevant to oncology. She will also discuss current efforts to expand the use of pharmacogenomic testing into current clinical practice.
|